Mehta, Puja http://orcid.org/0000-0001-9459-9306
Redhead, Gabrielle
Nair, Arjun
Sparks, Jeffrey A.
Porter, Joanna C.
Article History
Received: 22 May 2022
Revised: 10 June 2022
Accepted: 13 June 2022
First Online: 22 June 2022
Declarations
:
: PM is a Medical Research Council (MRC)-GlaxoSmithKline EMINENT clinical training fellow with project funding outside of the submitted work; PM reports consultancy fees from SOBI, Abbvie, EUSA Pharma, Boehringer Ingelheim and Lilly outside of the submitted work. <b>PM and JCP</b> receive co-funding by the National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre. JAS is supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (grant numbers R01 AR077607, P30 AR070253, and P30 AR072577) and the R. Bruce and Joan M. Mickey Research Scholar Fund. Dr. Sparks has received research support from Bristol Myers Squibb and performed consultancy for AbbVie, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Gilead, Inova Diagnostics, Janssen, Optum, and Pfizer unrelated to this work. JCP reports consultancy/ lecture fees from Astra Zeneca, Carrick Therapeutics and The Limbic, and funding from UKRI, LifeArc and Breathing Matters outside the submitted work.
Free to read: This content has been made available to all.